CPT code 23076 represents the surgical excision of an intramuscular mass or tumor in the shoulder, with the specimen being less than 5 cm including margins and submitted for pathological analysis. This code captures a targeted operative procedure on deep soft tissue of the shoulder that has implications for surgical coding, pathology processing, and postoperative care. Nationally, accurate use of this code affects surgical case reporting, quality measurement, and appropriate reimbursement for soft-tissue tumor management.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coding intent, typical clinical and site-of-service context, common modifiers associated with surgical procedures, and where to look for related documentation requirements. The publication also outlines benchmarking elements and policy considerations relevant to payers and providers, including coverage alignment for surgical excision, specimen submission for pathology, and coding nuances tied to lesion size and anatomic specificity.

This summary is intended to give clinicians, coders, and policy analysts a clear, national-level orientation to CPT code 23076, what it denotes clinically, and the practical points that commonly influence claim adjudication and clinical documentation.